Risk factors for cerebral amyloid angiopathy in the elderly

Annals of the New York Academy of Sciences

Volumn 977, Issue , 2002, Pages 37-44

  Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease (AD); Apolipoprotein E (APOE); Cerebral amyloid angiopathy (CAA); Elderly; Risk factors

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CHOLINESTERASE; PRESENILIN 1;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANAMNESIS; AUTOPSY; BRAIN ARTERY; BRAIN ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

EID: 0036451721     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04797.x     Document Type: Conference Paper

References (22)

1. Vinters, H.V. 1987. Cerebral amyloid angiopathy: A critical review. Stroke 18: 311-324.
2. Yamada, M. 2000. Cerebral amyloid angiopathy: An overview. Neuropathology 20: 8-22.
3. Yamada, M. et al. 1987. Cerebral amyloid angiopathy in the aged. J. Neurol. 234: 371-376.
4. Itoh, Y. et al. 1996. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke 27: 216-218.
5. Yamada, M. et al. 1996. Lack of the association between apolipoprotein E and cerebral amyloid angiopathy in the elderly Japanese. Ann. Neurol. 39: 683.
6. Yamada, M. et al. 1997. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 28: 2219-2221.
7. Yamada, M. et al. 1998. Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy. Ann. Neurol. 44: 129-131.
8. Yamada, M. et al. 1998. Butyrylcholinesterase K variant and cerebral amyloid angiopathy. Stroke 29: 2488-2490.
9. Yamada, M. et al. 1999. A deletion polymorphism of α2-macroglobulin gene and cerebral amyloid angiopathy. Stroke 30: 2277-2279.
10. Yamada, M. et al. 2002. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke 33: 896-900.
11. Itoh, Y. et al. 1999. Atherosclerosis is not implicated in association of APOE ε4 with AD. Neurology 53: 236-237.
12. Itoh, Y. et al. 1993. Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J. Neurol. Sci. 116: 135-141.
13. Mandybur, T.I. 1975. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 25: 120-126.
14. Premkumar, D.R.D. et al. 1996. Apolipoprotein E ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148: 2083-2095.
15. Lippa, C.F. et al. 1993. Vascular amyloid deposition in Alzheimer's disease: Neither necessary nor sufficient for the local formation of plaques or tangles. Arch. Neurol. 50: 1088-1092.
16. Ellis, R.J. et al. 1996. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV. Neurology 46: 1592-1596.
17. Greenberg, S.G. et al. 1995. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38: 254-259.
18. Nicoll, J.A.R. et al. 1997. High frequency of apolipoprotein E ε2 in hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 41: 716-721.
19. Wragg, M. et al. 1996. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347: 509-512.
20. Hayashi, Y. et al. 1998. Evidence for presenilin-1 involvement in amyloid angiopathy in the Alzheimer's affected brain. Brain Res. 7898: 307-314.
21. Kamboh, M.I. et al. 1995. APOE*4-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nat. Genet. 10: 486-488.
22. Ma, H. et al. 1994. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94.